> top > docs > PubMed:23180962 > annotations

PubMed:23180962 JSONTXT

Annnotations TAB JSON ListView MergeView

Allie

Id Subject Object Predicate Lexical cue
SS1_23180962_4_0 426-443 expanded denotes carbon nanofibers
SS2_23180962_4_0 445-448 abbr denotes CNF
SS1_23180962_4_1 462-491 expanded denotes poly(lactic-co-glycolic-acid)
SS2_23180962_4_1 493-497 abbr denotes PLGA
SS1_23180962_10_0 1315-1337 expanded denotes alpha-sarcomeric actin
SS2_23180962_10_0 1339-1344 abbr denotes α-SCA
AE1_23180962_4_0 SS1_23180962_4_0 SS2_23180962_4_0 abbreviatedTo carbon nanofibers,CNF
AE1_23180962_4_1 SS1_23180962_4_1 SS2_23180962_4_1 abbreviatedTo poly(lactic-co-glycolic-acid),PLGA
AE1_23180962_10_0 SS1_23180962_10_0 SS2_23180962_10_0 abbreviatedTo alpha-sarcomeric actin,α-SCA

PubMed_Structured_Abstracts

Id Subject Object Predicate Lexical cue
T1 130-757 BACKGROUND denotes Recent advances in nanotechnology (materials with at least one dimension between 1 nm and 100 nm) have led to the use of nanomaterials in numerous medical device applications. Recently, nanomaterials have been used to create innovative biomaterials for cardiovascular applications. Specifically, carbon nanofibers (CNF) embedded in poly(lactic-co-glycolic-acid) (PLGA) have been shown to promote cardiomyocyte growth compared with conventional polymer substrates, but the mechanisms involved in such events remain unknown. The aim of this study was to determine the basic mechanism of cell growth on these novel nanocomposites.
T2 767-1145 METHODS denotes CNF were added to biodegradable PLGA (50:50 PGA:PLA weight ratio) to increase the conductivity, mechanical and cytocompatibility properties of pure PLGA. For this reason, different PLGA to CNF ratios (100:0, 75:25, 50:50, 25:75, and 0:100 wt%) with different PLGA densities (0.1, 0.05, 0.025, and 0.0125 g/mL) were used, and their compatibility with cardiomyocytes was assessed.
T3 1155-2727 RESULTS denotes Throughout all the cytocompatibility experiments, cardiomyocytes were viable and expressed important biomarkers, including cardiac troponin T, connexin-43, and alpha-sarcomeric actin (α-SCA). Adhesion and proliferation experiments indicated that a PLGA density of 0.025 g/mL with a PLGA to CNF ratio of 75:25 and 50:50 (wt%) promoted the best overall cell growth, ie, a 55% increase in cardiomyocyte density after 120 hours compared with pure PLGA and a 75% increase compared with the control at the same time point for 50:50 (wt%). The PLGA:CNF materials were conductive, and their conductivity increased as greater amounts of CNF were added to pure PLGA, from 0 S · m(-1) for pure PLGA (100:0 wt%) to 5.5 × 10(-3) S · m(-1) for pure CNF (0:100 wt%), as compared with natural heart tissue (ranging from 0.16 S · m(-1) longitudinally to 0.005 S · m(-1) transversely). Tensile tests showed that the addition of CNF increased the tensile strength to mimic that of natural heart tissue, ie, 0.15 MPa for 100% PLGA to 5.41 MPa for the 50:50 (PLGA to CNF [wt%:wt%]) ratio at 0.025 g/mL. Atomic force microscopy indicated that the addition of CNF to PLGA increased the material surface area from 10% (100:0 [PLGA to carbon nanofiber (wt%:wt%)]) to over 60% (50:50 [PLGA to carbon nanofibers (wt%:wt%)]). Lastly, the adsorption of specific proteins (fibronectin and vitronectin) showed significantly more adsorption for the 50:50 PLGA to CNF (wt%:wt%) ratio at 0.025 g/mL PLGA compared with pure PLGA, which may be why cardiomyocyte function increased on CNF-enriched composites.
T4 2740-3035 CONCLUSIONS denotes This study demonstrates that cardiomyocyte function was enhanced on 50:50 PLGA to CNF (wt%:wt%) composite ratios at 0.025 g/mL PLGA densities because they mimicked native heart tissue tensile strength/conductivity and increased the adsorption of proteins known to promote cardiomyocyte function.